Symptomatic thromboembolic complications of central venous catheters (CVCs) occur in 5%
or less of general oncology patients. Asymptomatic CVC-related thrombi are more common …

Symptomatic catheter related thrombosis (CRT) occurs in 4%–8% of cancer patients. The
mean incidence of CRT, detected either by echography or Doppler ranges between 12 and …

Central venous catheters are extensively used in patients with cancer to secure delivery of
chemotherapy and facilitate phlebotomy. Unfortunately, considerable morbidity can result …

Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the mechanism of thrombosis in CVCs. Explain the symptoms, signs, and sequelae …

Thrombotic complications associated with the use of central venous catheters (CVCs) are
common and lead to distressing patient symptoms, catheter dysfunction, increased risk of …

Objective: To review the literature regarding the incidence of thrombosis in cancer patients
with central venous catheters (CVCs) and weigh the evidence supporting …

The use of indwelling central venous catheters (CVCs) has improved the management of
patients with cancer. However, these devices can be complicated by thrombosis because of …

Central venous catheters (CVCs) have improved the management of patients with cancer
substantially, by facilitating chemotherapy and supportive therapy. The use of CVCs is …

A comment on this article appears in" Prophylaxis for venous thromboembolism in cancer
patients with a central vein catheter: new tones for an old song." J Clin Oncol. 2005 Oct 1; 23 …

Central venous catheters are essential to the modern-day management of many illnesses
especially cancer and hematologic disorders. Catheter malfunction due to catheter tip …